stella
beta
A Trial of SHR-A1811 Compared to Other Antitumor Therapies as Neoadjuvant Treatments in Early-stage or Locally Advanced HER2-positive Breast Cancer — Stella
Recruiting
Back to Early-stage or Locally Advanced HER2-positive Breast Cancer trials
Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.
Trial locations
(2 sites)
China
Shengjing Hospital, China Medical University, Shenyang, Liaoning
Fudan University Shanghai Cancer Center, Shanghai, Shanghai Municipality
View full record on ClinicalTrials.gov